Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials
2011; Lippincott Williams & Wilkins; Volume: 29; Issue: 20 Linguagem: Inglês
10.1200/jco.2010.33.5281
ISSN1527-7755
AutoresCharles D. Blanke, Brian M. Bot, David M. Thomas, Archie Bleyer, Claus-Henning Köhne, Michel Seymour, Aimery de Gramont, Richard M. Goldberg, Daniel J. Sargent,
Tópico(s)Colorectal Cancer Surgical Treatments
ResumoColorectal cancer predominantly occurs in the elderly, but approximately 5% of patients are 50 years old or younger. We sought to determine whether young age is prognostic, or whether it influences efficacy/toxicity of chemotherapy, in patients with advanced disease.
Referência(s)